Related Experiment Videos
Pituitary tumorigenesis and hPit-1 cells
1Laboratory of Molecular/Tumor Radiation Biology, Massachusetts General Hospital, Harvard Medical School, 02114, Boston, MA, USA. fpardo@ucsd.edu
Abstract:
Despite decades of clinical data verifying the success of therapeutic approaches to human pituitary tumors, a significant number of tumors progress and can be life-threatening. The development of better therapeutic strategies for pituitary tumors is complicated by the relative scarcity of human pituitary material for basic experimentation. Human pituitary tissue was used to derive cell cultures, and a cell line, hPIT-1. Molecular and functional analyses were used to further characterize the cells as human pituitary explants in vitro. Functional analyses of the cell cultures indicated that the cells were tumorigenic and of human folliculostellate origin. hPit-1 cells revealed numerous abnormalities of ploidy. Molecular analyses indicated the absence of expression of the following pituitary hormones or hormone subunits by this culture: growth hormone, prolactin, ACTH, FSHbeta, LHbeta, THbeta, and p-glycoprotein. By contrast, the cells expressed uniformly high levels of human follistatin mRNA. Finally, the cells are moderately tumorigenic in immune-deficient mice. Although the precise molecular genetic mechanisms for tumorigenesis in the established cell culture are unknown, the cells serve as a future resource in the study of pituitary tumor initiation, progression, and response to therapy.
Insights
Researchers developed a new human pituitary tumor cell line, hPIT-1, from patient tissue. This cell line exhibits abnormalities and can help study pituitary tumor growth and treatment.
Area of Science:
- Endocrinology
- Oncology
- Cell Biology
Background:
- Human pituitary tumors are a clinical challenge, with many progressing despite treatment.
- Limited human pituitary tissue hinders research into tumor development and therapy.
- Developing novel therapeutic strategies requires accessible experimental models.
Purpose of the Study:
- To establish and characterize a novel human pituitary tumor cell line for research.
- To investigate the tumorigenic potential and molecular characteristics of the new cell line.
- To provide a valuable resource for studying pituitary tumor initiation, progression, and treatment response.
Main Methods:
- Derivation of a cell line (hPIT-1) from human pituitary tumor tissue.
- In vitro characterization using molecular and functional analyses.
- Assessment of tumorigenicity in immune-deficient mice.
Main Results:
- The hPIT-1 cell line, derived from human pituitary explants, demonstrated tumorigenic properties.
- hPIT-1 cells exhibited significant ploidy abnormalities and lacked expression of key pituitary hormones.
- High levels of human follistatin mRNA were uniformly expressed, and cells were moderately tumorigenic in vivo.
Conclusions:
- The hPIT-1 cell line represents a novel in vitro model for human pituitary tumors.
- Despite unknown tumorigenesis mechanisms, this cell line offers a resource for pituitary tumor research.
- Further studies using hPIT-1 can advance understanding of pituitary tumor biology and therapeutic interventions.